Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide in TACE for Hepatocellular Carcinoma
NCT02018757Phase 2Unknown
- Sponsor
- First Hospital of China Medical University
- Start
- Jan 2014
- Primary completion
- Dec 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of arsenic trioxide in hepatocellular carcinoma (HCC), sponsored by First Hospital of China Medical University. Status: unknown.
02
Drugs
arsenic trioxide
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02018757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02018757.